Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul 25;499(3):143-8.
doi: 10.1016/j.neulet.2011.05.056. Epub 2011 Jun 6.

Oligodendrocyte vulnerability following traumatic brain injury in rats

Affiliations

Oligodendrocyte vulnerability following traumatic brain injury in rats

George Lotocki et al. Neurosci Lett. .

Erratum in

  • Neurosci Lett. 2012 May 10;516(1):166. de Rivero Vaccari, Juan [corrected to de Rivero Vaccari, Juan Pablo]

Abstract

Experimental and clinical findings demonstrate that traumatic brain injury (TBI) results in injury to both gray and white matter structures. The purpose of this study was to document patterns of oligodendrocyte vulnerability to TBI. Sprague Dawley rats underwent sham operated procedures or moderate fluid percussion brain injury. Quantitative immunohistochemical analysis was performed on animals perfusion-fixed at 3 (n=9) or 7 (n=9) days post-surgery. Within the ipsilateral external capsule and corpus callosum, numbers of APC-CC1 immunoreactive oligodendrocytes were significantly decreased at 3 or 7 days post-TBI compared to sham rats (p<0.03). At both posttraumatic survival periods, double-labeling studies indicated that oligodendrocytes showed increased Caspase 3 activation compared to sham. These data demonstrate regional patterns of oligodendrocyte vulnerability after TBI and that oligodendrocyte cell loss may be due to Caspase 3-mediated cell death mechanisms. Further studies are needed to test therapeutic interventions that prevent trauma-induced oligodendrocyte cell death, subsequent demyelination and circuit dysfunction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Micrographs of CC1 immunoreactive oligodendrocytes. Sham (A) animal exhibiting robust staining of CC1 positive cells in the external capsule (B) and corpus callosum (C). In contrast, at 3 days post-TBI animal (D) shows reduced numbers of CC1 positive cells in the external capsule (E) and corpus callosum (F). Magnification 1X (A,D), 10X (B, C, E, F), inset of B, C, E, F (20X).
Figure 2
Figure 2
Confocal micrographs of representative double-labeled CC1 and GFAP immunoreactive cells. CC1 (red) and GFAP (green) positive cells in the external capsule (Row 1) and corpus callosum (Row 2) were investigated in traumatized rats 7 days post injury. CC1 and GFAP colocalization was not observed in these regions of the rat brain (Merged). Bar = 10 microns.
Figure 3
Figure 3
Confocal micrographs of representative double-labeled CC1 (red)/Caspase 3 (green) positive cells in the external capsule. Sham animals showed CC1 positive cells with no Caspase 3 positive cells (Row 1). In contrast, a 3 day TBI animal demonstrates robust double-labeling (merged) of Caspase 3 and CC1 indicating apoptotic cell death of these oligodendrocyte (Row 2, arrows). Bar = 10 microns.
Figure 4
Figure 4
Quantitative assessment of CC1 positive cells within vulnerable white matter regions. A. Representative micrograph indicating where the stereological cell counts were conducted, corpus callosum (a) and external capsule (b). B. T-test was significant (p<0.001) for both time points compared to sham in the corpus callosum. Both 3 and 7 day TBI animals showed significant (*p<0.001) reductions in CC1 positive cells compared to sham. C. T-test was significant (*p<0.02) for the 3 day TBI group compared to sham in the external capsule. These data demonstrate a reduction in the number of CC1 positive cells in the 3 day TBI group compared to sham.

References

    1. Bhat RV, Axt KJ, Fosnaugh JS, Smith KJ, Johnson KA, Hill DE, Kinzler KW, Baraban JM. Expression of the APC tumor suppressor protein in oligodendroglia. Glia. 1996;17:169–174. - PubMed
    1. Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab. 2004;24:133–150. - PubMed
    1. Bramlett HM, Dietrich WD. Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog Brain Res. 2007;161:125–141. - PubMed
    1. Bramlett HM, Dietrich WD. Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats. Acta Neuropathol (Berl) 2002;103:607–614. - PubMed
    1. Bramlett HM, Kraydieh S, Green EJ, Dietrich WD. Temporal and regional patterns of axonal damage following traumatic brain injury: a beta-amyloid precursor protein immunocytochemical study in rats. J Neuropathol Exp Neurol. 1997;56:1132–1141. - PubMed

Publication types

Substances